Clinical Trial Update: Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients [Phase 3]

View source ↗

Summary

This Phase 3 trial comparing enoxaparin (Lovenox) to heparin in gynecologic cancer patients reports an efficacy and safety update, with the study currently susp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer

Drugs mentioned

• Heparin (unfractionated heparin)
• Lovenox (enoxaparin)

Snippet

Sponsor: National Guard Health Affairs | Conditions: Malignant Female Reproductive System Neoplasm | Phase 3 | Status: SUSPENDED